Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity

Laquinimod is a novel oral drug that is currently being evaluated for the treatment of relapsing-remitting (RR) multiple sclerosis (MS). Using the animal model for multiple sclerosis, experimental autoimmune encephalomyelitis (EAE), we examined how laquinimod promotes immune modulation. Oral laquini...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Schulze-Topphoff, Ulf, Shetty, Aparna, Varrin-Doyer, Michel, Molnarfi, Nicolas, Sagan, Sharon A., Sobel, Raymond A., Nelson, Patricia A., Zamvil, Scott S.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2012
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3316495/
https://ncbi.nlm.nih.gov/pubmed/22479444
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0033797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados